The ERA Registry Annual Report 2022: Epidemiology of Kidney Replacement Therapy in Europe, with a focus on sex comparisons
Status PubMed-not-MEDLINE Jazyk angličtina Země Anglie, Velká Británie Médium electronic-ecollection
Typ dokumentu časopisecké články, přehledy
PubMed
40008269
PubMed Central
PMC11852260
DOI
10.1093/ckj/sfae405
PII: sfae405
Knihovny.cz E-zdroje
- Klíčová slova
- ESKD, dialysis, graft survival, kidney transplantation, patient survival,
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
The European Renal Association (ERA) Registry collects data on kidney replacement therapy (KRT) in patients with end-stage kidney disease (ESKD). This paper summarizes the ERA Registry Annual Report 2022, with a special focus on comparisons by sex. The supplement of this paper contains the complete ERA Registry Annual Report 2022. Data was collected from 53 national and regional KRT registries from 35 countries. Using this data, incidence, and prevalence of KRT, kidney transplantation rates, survival probabilities, and expected remaining lifetimes were calculated. In 2022, 530 million people of the European general population were covered by the ERA Registry. The incidence of KRT was 152 per million population (pmp). In incident patients, 54% were 65 years or older, 64% were male, and the most common primary renal disease (PRD) was diabetes mellitus (22%). At KRT initiation, 83% of patients received haemodialysis, 12% received peritoneal dialysis, and 5% underwent pre-emptive kidney transplantation. On 31 December 2022, the prevalence of KRT was 1074 pmp. In prevalent patients, 48% were 65 years or older, 62% were male, the most common PRD was of miscellaneous origin (18%), 56% of patients received haemodialysis, 5% received peritoneal dialysis, and 39% were living with a functioning graft. In 2022, the kidney transplantation rate was 40 pmp, with most kidneys coming from deceased donors (66%). For patients starting KRT between 2013 to 2017, 5-year survival probability was 52%. Compared with the general population, the expected remaining lifetime was 66% and 68% shorter for males and females, respectively, receiving dialysis, and 46% and 49% shorter for males and females, respectively, living with a functioning graft.
Abdominal Center Nephrology University of Helsinki and Helsinki University Hospital Helsinki Finland
Amsterdam Public Health Quality of Care and Ageing and Later Life Amsterdam The Netherlands
Amsterdam Public Health Quality of Care and Methodology Amsterdam The Netherlands
B Braun Avitum Hungary Zrt Dialysis Center Budapest Budapest Hungary
Clinic for Nephrology Clinical Center of Montenegro Podgorica Montenegro
Clinic of Nephrology Clinical Center of Serbia Belgrade Serbia
Clinical Nephrology Puerta de Hierro University Hospital Majadahonda Spain
Cyprus Renal Registry Health Monitoring Unit Ministry of Health Nicosia Cyprus
Department of Internal Diseases Riga Stradins University Riga Latvia
Department of Medicine Jönköping Regional Hospital Jönköping Sweden
Department of Nephrology and Hypertension IIS Fundacion Jimenez Diaz UAM Madrid Spain
Department of Nephrology Holbaek Hospital Holbaek Denmark
Department of Nephrology Pauls Stradins Clinical University Hospital Riga Latvia
Division of Nephrology Internal Medicine Services Landspitali University Hospital Reykjavik Iceland
Faculty of Medicine Autonoma University of Madrid Madrid Spain
Faculty of Medicine Ss Cyril and Methodius Skopje North Macedonia
Faculty of Medicine Tel Aviv University Tel Aviv Israel
Faculty of Medicine University of Belgrade Belgrade Serbia
Finnish Registry for Kidney Diseases Finnish Institute for Health and Welfare Helsinki Finland
Hospital Universitario de Navarra Pamplona Navarra Spain
Institute of Nephrology and Hypertension Sheba Medical Center Ramat Gan Israel
Institute of Nephrology Stadtspital Zürich Zürich Switzerland
Istanbul Üniversity Cerrahpasa Cerrahpasa Medical Faculty Istanbul Turkey
Lithuanian Nephrology Dialysis and Transplantation Association Lithuania
Murcia Renal Registry Department of Epidemiology Murcia Regional Health Council Murcia Spain
Nefrodata Dutch Renal Registry Utrecht the Netherlands
Nephrology Clinic University Clinical Centre of Kosovo Prishtina Kosovo
Nephrology Department Medical Academy Lithuanian University of Health Sciences Kaunas Lithuania
Nephrology department Nicosia General Hospital State Healthcare Services Organisation Nicosia Cyprus
Nephrology Department Valdecilla Hospital University of Cantabria IDIVAL Santander Spain
Registry of La Rioja Department Nephrology Hospital San Pedro Logroño La Rioja Spain
REIN registry Agence de la Biomédecine Saint Denis La Plaine Saint Denis France
Scottish Renal Registry Public Health Scotland Glasgow UK
Slovak Medical University Faculty of Medicine Bratislava Slovakia
St Imre Teaching Hospital Div Nephrology Hypertension Budapest Hungary
Tartu University Faculty of Medicine Department of Internal Medicine Tartu Estonia
Tartu University Hospital Department of Internal Medicine Tartu Estonia
Transplant Autonomic Coordination Department Health Service of Castilla y León Castilla y León Spain
University Clinic of Nephrology Skopje North Macedonia
University of Cyprus Shacolas Education Centre for Clinical Medicine Nicosia Cyprus